chr21-46136261-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000494498(FTCD):c.*236C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00171 in 591,536 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0049 ( 4 hom., cov: 30)
Exomes 𝑓: 0.00060 ( 2 hom. )
Consequence
FTCD
ENST00000494498 3_prime_UTR
ENST00000494498 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.271
Genes affected
FTCD (HGNC:3974): (formimidoyltransferase cyclodeaminase) The protein encoded by this gene is a bifunctional enzyme that channels 1-carbon units from formiminoglutamate, a metabolite of the histidine degradation pathway, to the folate pool. Mutations in this gene are associated with glutamate formiminotransferase deficiency. Alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Dec 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 21-46136261-G-A is Benign according to our data. Variant chr21-46136261-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 369369.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0049 (746/152238) while in subpopulation AFR AF= 0.017 (705/41542). AF 95% confidence interval is 0.0159. There are 4 homozygotes in gnomad4. There are 328 alleles in male gnomad4 subpopulation. Median coverage is 30. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
use as main transcript | n.46136261G>A | intergenic_region | ||||||
FTCD | NM_001320412.2 | c.*193C>T | downstream_gene_variant | NP_001307341.1 | ||||
FTCD | NM_006657.3 | c.*236C>T | downstream_gene_variant | NP_006648.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FTCD | ENST00000494498 | c.*236C>T | 3_prime_UTR_variant | 6/6 | 3 | ENSP00000507847.1 | ||||
FTCD | ENST00000397748.5 | c.*193C>T | downstream_gene_variant | 1 | ENSP00000380856.1 | |||||
FTCD | ENST00000291670.9 | c.*236C>T | downstream_gene_variant | 1 | ENSP00000291670.5 |
Frequencies
GnomAD3 genomes AF: 0.00490 AC: 746AN: 152120Hom.: 4 Cov.: 30
GnomAD3 genomes
AF:
AC:
746
AN:
152120
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000601 AC: 264AN: 439298Hom.: 2 Cov.: 4 AF XY: 0.000510 AC XY: 117AN XY: 229250
GnomAD4 exome
AF:
AC:
264
AN:
439298
Hom.:
Cov.:
4
AF XY:
AC XY:
117
AN XY:
229250
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00490 AC: 746AN: 152238Hom.: 4 Cov.: 30 AF XY: 0.00441 AC XY: 328AN XY: 74442
GnomAD4 genome
AF:
AC:
746
AN:
152238
Hom.:
Cov.:
30
AF XY:
AC XY:
328
AN XY:
74442
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Myosclerosis Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Collagen 6-related myopathy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at